Health PEI: Provincial Antibiotic Advisory Team Urinary Tract Infection Empiric Treatment Guidelines
|
|
- Verity Ross
- 6 years ago
- Views:
Transcription
1 Syndrome Urinary Tract Infection (Antibiotics are listed in the numerical order of preference.) (Tailoring of treatment after susceptibilities are known is highly recommended.) Health PEI: Provincial Antibiotic Advisory Team Urinary Tract Infection Empiric Treatment Guidelines Prevention Cranberry juice?, Estrogenized vaginal mucosa, controlled diabetes and stones. Remove indwelling Foley Catheter Major Hurdles True symptoms?, previous Antibiotics past days (esp. same class), Pregnancy, travel outside of Canada. Considerations prostatitis, vaginitis, PID, urethritis as mimics. Tuberculosis as culture negative disease. Non-SIRS / Pre-SIRS FEMALE CYSTITIS (<6d Symptoms) 1. Nitrofur. x 5d (if CrCl > 60 ml/min)* 2. TMP/SMX x 3d 3. Cefixime x 5-7d 4. Amox/Clav x 5-7d MALE CYSTITIS and EARLY MALE or FEMALE PYELONEPHRITIS 1. Cipro x7d 2. TMP/SMX x10-14d 3. Cefixime x 14d 4. Amox/Clav TID x14d IF in ER or on a unit: Add 1g or Tobra 5mg/kg x1 for pyelonephritis SIRS / Sepsis (2 of 4) >38.3<36.0; HR>; RR>20 or PaCO2<32; WBC <4 >12 or Bands Severe Sepsis(1 of 7+) Mottled, anuria, Lactate>2, Plt<, DIC, ARDS, fastδloc Septic Shock (Pressors) Refractory Septic Sh. (More Pressors) In Absence of Indwelling Foley Catheter or Urinary Stent 1. Amp & Tobra 2. Ceftazidime 3. See Early Pyelo for non-admission Tx. Pip/Tazo & Cipro If penicillin allergy: Mero & Cipro Mero & Tobra Or Mero & Cipro (Renal Sparing) In Presence of Indwelling Foley Catheter or Urinary Stent (Catheter should be removed or changed) Mero, Vanco, &Fluconazole Add Cipro or Tobra if growth of previous P. aeruginosa(d). 1. Pip/Tazo 2. Meropenem If previous culture (d) or stat gram points to yeast, Enterococcus or MRSA -add therapy. As above and add Vanco (or Linezolid if VRE is a concern) Add Fluconazole or Amphotericin-B RE: Penicillin allergy: Avoid pip/tazo, but meropenem is reasonable to give in severe sepsis or greater even with history of anaphylaxis. Consult Inf. Dis. if in doubt. *Nitrofurantoin should not be used with abnormal kidney function (CrCl < 60 ml/min) and is discouraged for long term prophylaxis in the elderly(potential for pulmonary toxicity, inadequate concentrations in the urine in pt with CrCl< 60 ml/min). If financially feasible, Macrobid twice daily versus nitrofurantoin four times daily formulations is strongly preferred for patient adherence. Logic for guidelines: 1. The oral antibiotic that urinary isolates of E. coli in PEI have the highest susceptibility to is nitrofurantoin. As per the Health PEI Antibiogram 2013, the local susceptibilities of urine isolates of E. coli to select antibiotics are as follows: nitrofurantoin %, TMP/SMX 83%, cefixime %, amoxicillin/clavulanate 88%, ciprofloxacin 85%. Cephalexin data (59%) is difficult to interpret due to changes in internationally set breakpoints for susceptibility. Yet cephalexin does concentrate in the urine, which would increase its effectiveness beyond 59%. 2. Avoid collateral damage: nitrofurantoin does not have a serious effect on other bacteria outside the urinary tract, TMP/SMX has lower C. difficle risk than levofloxacin, ciprofloxacin, or amoxicillin/clavulanate. 3. Nitrofurantoin should NOT be used for pyelonephritis or secondary bacteremia due to inadequate tissue and serum concentrations. 4. A recent article reviewed the literature on nitrofurantoin use in renal dysfunction. The authors of this article suggest that nitrofurantoin is effective and safe to use for shortterm treatment ( 1 week) in patients with a CrCl > 40 ml/min. (Oplinger M and Andrews CO 2013 Nitrofurantoin Contraindication in Patients with a Creatinine Clearance Below 60 ml/min: Looking for the Evidence. The Annals of Pharmacotherapy 47: 106.) Approved: May, 2013 This document is designed to aid Prince Edward Island hospital and community practitioners in the appropriate utilization of antimicrobials. Next Review: May, 2015 It does not serve as a substitute for clinical judgment or consultation with Infectious Disease experts.
2 Health PEI: Provincial Antibiotic Advisory Team Urinary Tract Infection Empiric Treatment Guidelines Logic for guidelines (continued): 5. Resistance to levofloxacin and ciprofloxacin is greater than 10% which necessitates conservation (limit use in non-serious infections or prophylaxis) and supplementation (addition of a second agent is recommended for the treatment of serious infections). IDSA guidelines recommend, for treatment of pyelonephritis, when there is >10% fluoroquinolone resistance, an initial one-time IV/IM dose of a long-acting antimicrobial (such as ceftriaxone or an aminoglycoside) be given. Furthermore, fluoroquinolone toxicity is an increasing concern such as retinal detachment, ligament tears in the elderly or on steroids, and QT-interval prolongation (especially in patients with other risk factors). Moxifloxacin should never be used to treat a UTI because it does not concentrate in the urine. The PAAT discussed adding levofloxacin high dose (750 mg po daily) x5 days in addition to having an option for ciprofloxacin 500 mg po bid x 7days for the treatment of early pyelonephritis. Due to the Special Authorization criteria for levofloxacin on the PEI Pharmacare Formulary and lack of clarity on using levofloxacin high dose x 5 days for this indication, we have decided not to include levofloxacin high dose as an option at this time. 6. Enterococcus has relatively low virulence. Enterococcal UTIs are most often nosocomial and/or associated with obstruction, urinary catheterization or instrumentation. In patients with long-term catheterization, urine cultures obtained before and after the catheter was replaced showed that the mean concentration of Enterococci were >10- fold higher in the indwelling catheter than they were in the replacement catheter. 7. Gentamicin vs tobramycin: gentamicin is considered more nephrotoxic than tobramycin and tobramycin has a greater spectrum of activity for empiric treatment of UTIs. References: 1. Epp A. Larochelle A. et al 2010 SOGC Clinical Practice Guidelines Recurrent Urinary Tract Infection. JOGC. 250: Gupta, K. et al 2011 International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. CID 52:e Hooton TM et al Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America CID 50: Blondel-Hill E. and Fryters S. Bugs & Drugs Capital Health (QE2) Antimicrobial Handbook Vancouver Island Health Authority (VIHA) Cowichan District Hospital. Antimicrobial Empiric Prescribing Guidelines Adults (Edition 2) 7. The Ottawa Hospital (TOH) Guidelines for Empiric Antibiotic Therapy (2012) 8. Drugs for Urinary Tract Infections. The Medical Letter on Drugs and Therapeutics :57 9. Health PEI Antibiogram Etminan M. et al 2012 Oral Fluoroquinolones and the Risk of Retinal Detachment. JAMA 307: Khaliq Y. and Zhanel G Fluoroquinolone-Associated Tendinopathy: A Critical Review of the Literature. CID 36: The American Geriatrics Society 2012 Beers Criteria Update Expert Panel American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 60: Oplinger M and Andrews CO 2013 Nitrofurantoin Contraindication in Patients with a Creatinine Clearance Below 60 ml/min: Looking for the Evidence. The Annals of Pharmacotherapy 47: accessed Feb 4, Bains A. et al A retrospective review assessing the efficacy and safety of nitrofurantoin in renal impairment. CPJ 142: Murray BE Treatment of enterococcal infections. UpToDate (accessed Feb 4, 2013) 17. Solensky R Penicillin-allergic patients: Use of cephalosporins, carbapenems, and monobactams. UpToDate (accessed Jan 3, 2013) 18. Romano A. et al Brief Communication: Tolerability of Meropenem in Patients with IgE-Medicated Hypersensitivity to Penicillins. Annals of Internal Medicine 146: Atanasković-Marković M. et al Tolerability of Meropenem in Children with IgE-mediated Hypersensitivity to Penicillins. Allergy 63: Decker BS. Molitoris BA Pathogenesis and prevention of aminoglycosides nephrotoxicity and ototoxicity. UpToDate (accessed Feb 4, 2013). Health PEI Physician Reviewers: Dr. Lenley Adams, Dr. Scott Campbell, Dr. Greg German, Dr. Kate Ellis-Ghiz, Dr. Gil Grimes, Dr. Michael Irvine, Dr. Ian Reid, Dr. John Sampson Approved: May, 2013 This document is designed to aid Prince Edward Island hospital and community practitioners in the appropriate utilization of antimicrobials. Next Review: May, 2015 It does not serve as a substitute for clinical judgment or consultation with Infectious Disease experts.
3 Provincial Drugs & Therapeutics Committee 16 Garfield Street 16, rue Garfield PO Box 2000, Charlottetown C.P. 2000, Charlottetown Prince Edward Island Île-du-Prince-Édouard Canada C1A 7N8 Canada C1A 7N8 From: Provincial Drugs and Therapeutics Committee To: All Island Physicians, Nurse Practitioners, and Pharmacists Date: May 24, 2013 RE: Provincial Urinary Tract Infection Empiric Treatment Guidelines and Health PEI Antibiogram Consideration of local susceptibly patterns is crucial to empirically treating infections and reducing the spread of antibiotic resistance. Our Island wide Health PEI Antibiogram 2013, based on 2012 data, is attached and available at This data is from all community and hospital specimens received, removing duplicated specimens for better quality. Dr. Greg German, Medical Microbiologist, gave grand round presentations at QEH and PCH in the Fall introducing the antibiogram as it pertains to UTIs and how it may affect your practice. The Provincial Antibiotic Advisory Team (PAAT), of which Dr. German is co-chair, has developed the enclosed UTI Empiric Treatment Guidelines which were adapted and approved by a well-represented committee of Physician Reviewers. The guidelines are based on local susceptibilities and are in keeping with national and international guidelines. Individual medication recommendations do not necessarily take into account coverage by PEI Pharmacare or private drug plans. The guidelines were developed with the desire to appropriately and safely treat urinary tract infections while reducing collateral damage and attempting to save fluoroquinolones for more serious infections. The layout of the guidelines includes preventative and diagnostics tips, followed by a list of empiric treatment options spanning the continuum of patients illness from generally well to septic shock. This standardization should allow for a rapid, consistent, and collaborative approach for almost all patients on the Island. It is important to note that these guidelines were not designed for special populations such as paediatrics, pregnancy or patients with severe renal impairment. The guidelines are further categorized by the following: in patients who are non-sirs or pre-sirs, empiric antibiotic treatment differs for female cystitis (< 6 days of symptoms) versus male cystitis/early male or female pyelonephritis. For patients anywhere across the spectrum from generally well to refractory septic shock, the suggested treatment options differ for those with or without an indwelling Foley catheter or urinary stent.
4 Provincial Drugs & Therapeutics Committee The new guidelines will potentially change routine practices. For example: 1) Nitrofurantoin is suggested as the first option for female cystitis (if no contraindication for use). Fluoroquinolones are not listed as one of the top four agents for the treatment of female cystitis. It is encouraged that fluoroquinolones be reserved for more serious infections. 2) Due to the level of ciprofloxacin resistance (E. coli resistance to ciprofloxacin is 15%), an initial onetime IV dose of a long-acting parenteral antimicrobial (such as ceftriaxone or a consolidated 24h dose of an aminoglycoside) as a second agent is recommended when possible, when treating early pyelonephritis. 3) Ampicillin and tobramycin are recommended as first line therapy in patients with SIRS or sepsis without an indwelling Foley catheter or urinary stent. It is recommended to step-down from ampicillin and tobramycin as early as possible to avoid aminoglycoside toxicities. 4) For SIRS or sepsis patients with an indwelling Foley catheter or urinary stent, the use of a stat urine Gram stain to check for yeast, MRSA or Enterococcus is recommended. 5) The cross reactivity of truly penicillin-allergic patients with meropenem is less than 1%. Meropenem is a reasonable choice to give to serious penicillin-allergic patients in severe disease. The Urinary Tract Infection Empiric Treatment Guidelines is the first of a series of guidelines the Provincial Antibiotic Advisory Team is working on developing. Guidelines for Clostridium difficile and skin and soft tissue infections are to come out in the next few months. For any questions about the Health PEI Antibiogram 2013, please contact Greg German (8-2515; GJGerman@ihis.org). For questions on the Provincial UTI Empiric Treatment Guidelines, you can contact the PAAT co-chairs Greg German or Jennifer Boswell (antimicrobial pharmacist; 8-27; jlboswell@ihis.org). 2
5 URINE Isolates Total (7 months) E. coli 2221 Klebsiella pneumoniae 333 Klebsiella oxytoca 63 Enterobacter 92 Proteus mirabilis (Not P. vulgaris) 124 Pseudomonas aeruginosa 87 Staphylococcus saphrophyticus 147 Enterococcus 352 Nitrofurantoin* AmpIV / AmoxPO Amox + Clav. Acid Cephalexin Cefixime Ciprofloxacin Ceftazidime Ertapenem Piperacillin+Tazo Meropenem Tobramycin ^ ^ 76^ Vancomycin IV or Linezolid PO / IV : Predictably Resistant ; ^Urine inc. levels = likely higher % *Nitrofurantoin activity limited to bladder (uncomplicated UTIs only) ALL Gram Negative ISOLATES (Except URINE) Total (12 Months) E. coli 182 Klebsiella 76 Proteus mirabilis 11 Enterobacter 49 Citrobacter 16 Serratia 22 Acinetobacter 7 Pseudomonas aeruginosa 261 AmpIV /AmoxPO Amox +Clav. Acid Cephalexin Cefprozil Cefixime Ciprofloxacin Cefazolin Ceftazidime Ertapenem Piperacillin+Tazo Meropenem Tobramycin 92 Gram Positive Cocci GPC (Except URINE) Total Number (12 Months) Amp IV or Amox Amox+Clav. Acid Cephalexin or Cefazolin Cefuroxime or Doxycylcine (Tetracycline) Staph. aureus MSSA & MRSA to * Staphylococcus lugdunensis (SL) Coagulase Neg. Staph (Except SL) Enterococcus Sample Group A Strep of 75 ~ Sample Group B Strep of ~ Streptococcus pneumoniae ^ 85^ 85 ~60 ~70 79 ~ *MRSA Rate: 7.4% of Blood Cultures; 18% of Wounds (QEH and PCH Emerg.) ~National data as local data is unavailable. : Predictably Resistant S. pneumoniae and Levofloxacin (%), in vitro testing not reliable for other GPC. ^85% at regular dose, % at high dose in non-central Nervous System Infections. Erythromycin Clindamycin Vancomycin IV Health PEI ANTIBIOGRAM 2013 (Island-wide Antibiotic Susceptibility Results of Non-duplicative Isolates) Medical Microbiologist: Head Microbiology Technologists: Dr. Greg German Andrea Dowling Secretary: # QEH Laboratory # QEH Switchboard for Becky Moore Direct line or Page PCH Laboratory # Anaerobic susceptibilities* Predictably Susceptible: Amoxicillin+Clavulanic Acid, Pipercillin+Tazobactam, Ertapenem, and Meropenem; Also Predictably Susceptible: Metronidazole (Yet Actinomyces or Propionibacterium are intrinsically resistant) Double anaerobic coverage when already on one of above antibiotics is discouraged. NOT-Predictably Susceptible: Moxifloxacin, Doxycycline, Cefoxitin or Clindamycin Note: Most beta-lactamase negative oral anaerobes are susceptible to Amoxicillin. *Bugs and Drugs (Canada) 2012; Susceptibilities available on a case by case basis.
Provincial Drugs & Therapeutics Committee Memorandum Version 2
Provincial Drugs & Therapeutics Committee Memorandum Version 2 16 Garfield Street 16, rue Garfield PO Box 2000, Charlottetown C.P. 2000, Charlottetown Prince Edward Island Île-du-Prince-Édouard Canada
More informationHealth PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults
Health PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults COMMUNITY-ACQUIRED PNEUMONIA HEALTHCARE-ASSOCIATED PNEUMONIA INTRA-ABDOMINAL INFECTION
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationAberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015
Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationAntibiotic Updates: Part II
Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationAntibiotic Stewardship Program (ASP) CHRISTUS SETX
Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More information2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
More information2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More information1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient
1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime
More informationAntibiotic Abyss. Discussion Points. MRSA Treatment Guidelines
Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California
More information10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally
Low: not well absorbed PO agent not for serious infection nitrofurantoin Good: [blood and tissue] < than if given IV [Therapeutic] in excess of [effective] eg. cephalexin High: > 90% absorption orally
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More information2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationGuidelines for Treatment of Urinary Tract Infections
Guidelines for Treatment of Urinary Tract Infections Overview This document details the Michigan Hospital Medicine Safety (HMS) Consortium preferred antibiotic choices for treatment of uncomplicated and
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More information2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services
2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.
More informationAdvanced Practice Education Associates. Antibiotics
Advanced Practice Education Associates Antibiotics Overview Difference between Gram Positive(+), Gram Negative(-) organisms Beta lactam ring, allergies Antimicrobial Spectra of Antibiotic Classes 78 Copyright
More informationSimilar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.
Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity. Cephalosporins are divided into Generations: -First generation have better activity against gram positive organisms. -Later compounds
More informationPreserve the Power of Antibiotics
PROVIDERInsight News for providers in Northeast Nebraska April 2016 Preserve the Power of Antibiotics Antimicrobial stewardship interventions have been proven to improve individual patient outcomes, reduce
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationPerichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV
Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationPrinciples of Infectious Disease. Dr. Ezra Levy CSUHS PA Program
Principles of Infectious Disease Dr. Ezra Levy CSUHS PA Program I. Microbiology (1) morphology (e.g., cocci, bacilli) (2) growth characteristics (e.g., aerobic vs anaerobic) (3) other qualities (e.g.,
More informationRCH antibiotic susceptibility data
RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological
More informationCUMULATIVE ANTIBIOGRAM
BC Children s Hospital and BC Women s Hospital & Health Centre CUMULATIVE ANTIBIOGRAM 2017 Division of Medical Microbiology Department of Pathology and Laboratory Medicine Page 1 of 5 GRAM-POSITIVE BACTERIA
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More informationApproach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
More informationAntimicrobial utilization: Capital Health Region, Alberta
ANTIMICROBIAL STEWARDSHIP Antimicrobial utilization: Capital Health Region, Alberta Regionalization of health care services in Alberta began in 1994. In the Capital Health region, restructuring of seven
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationInfectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles
Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles Conflicts of Interest None at this time May be discussing off-label indications KALIN M. CLIFFORD, PHARM.D., BCPS,
More informationAntimicrobial susceptibility
Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL
More informationINFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER
INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER University of Minnesota Health University of Minnesota Medical Center University of Minnesota Masonic Children s Hospital May 2017 Printed herein are
More informationUTI Dr S Mathijs Department of Pharmacology
UTI Dr S Mathijs Department of Pharmacology Introduction Responsible for > 7 million consultations annually 15% of all antibiotic prescriptions 40% of all hospital acquired infections Significant burden
More informationSurveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler
Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level janet hindler At the conclusion of this talk, you will be able to Describe CLSI M39-A3 recommendations
More information2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital
2010 ANTIBIOGRAM University of Alberta Hospital and the Stollery Children s Hospital Medical Microbiology Department of Laboratory Medicine and Pathology Table of Contents Page Introduction..... 2 Antibiogram
More informationAntimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018
Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?
More informationNorthwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16
Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 These criteria are based on national and local susceptibility data as well as Infectious Disease Society of America
More informationDr. Shaiful Azam Sazzad. MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College
Dr. Shaiful Azam Sazzad MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College INTRODUCTION ICU acquired infection account for substantial morbidity, mortality and expense. Infection and
More informationPrudent Use of Antibiotics in Long Term Care Residents with Suspected UTI
Prudent Use of Antibiotics in Long Term Care Residents with Suspected UTI Shira Doron, MD Assistant Professor of Medicine Division of Geographic Medicine and Infectious Diseases Tufts Medical Center Boston,
More information11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1
Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director
More informationAntimicrobial Stewardship 101
Antimicrobial Stewardship 101 Betty P. Lee, Pharm.D. Pediatric Infectious Disease/Antimicrobial Stewardship Pharmacist Lucile Packard Children s Hospital Stanford Disclosure I have no actual or potential
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationPharmacology Week 6 ANTIMICROBIAL AGENTS
Pharmacology Week 6 ANTIMICROBIAL AGENTS Mechanisms of antimicrobial action Mechanisms of antimicrobial action Bacteriostatic - Slow or stop bacterial growth, needs an immune system to finish off the microbe
More information* gender factor (male=1, female=0.85)
Usual Doses of Antimicrobials Typically Not Requiring Renal Adjustment Azithromycin 250 500 mg Q24 *Amphotericin B 1 3-5 mg/kg Q24 Clindamycin 600 900 mg Q8 Liposomal (Ambisome ) Doxycycline 100 mg Q12
More informationPRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE
PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse
More informationClinical Practice Standard
Clinical Practice Standard 1-20-6-1-010 TITLE: INTRAVENOUS TO ORAL CONVERSION FOR ANTIMICROBIALS A printed copy of this document may not reflect the current, electronic version on OurNH. APPLICABILITY:
More informationTrea%ng Sepsis in 2016 Are the Big Guns Losing the War?
Trea%ng Sepsis in 2016 Are the Big Guns Losing the War? ERIC HODGSON FCA (Crit Care) Inkosi Albert Luthuli Central Hospital & NELSON R MANDELA SCHOOL OF MEDICINE DURBAN, KZN Declaration Advisory boards
More informationConsiderations in antimicrobial prescribing Perspective: drug resistance
Considerations in antimicrobial prescribing Perspective: drug resistance Hasan MM When one compares the challenges clinicians faced a decade ago in prescribing antimicrobial agents with those of today,
More information2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital
2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....
More informationOther Beta - lactam Antibiotics
Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics
More informationجداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
More informationInteractive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe
Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic
More informationAppropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases
Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationBACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)
BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016) VA Palo Alto Health Care System April 14, 2017 Trisha Nakasone, PharmD, Pharmacy Service Russell Ryono, PharmD, Public Health Surveillance
More informationHost, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus
Host, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus Montana ACP Meeting 2018 September 8, 2018 Staci Lee, MD, MEHP Billings
More informationDiscussion Points. Decisions in Selecting Antibiotics
Antibiotics in Acute Care Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical
More informationThe β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXXII NUMBER 6 September 2017 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Stacey Hamilton MT SM (ASCP), Samuel Dominguez MD PhD, Sarah Parker MD, and
More informationAntibiotic Updates: Part I
Antibiotic Updates: Part I Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More informationCipro for gram positive cocci in urine
Buscar... Cipro for gram positive cocci in urine 20-6-2017 Pneumonia can be generally defined as an infection of the lung parenchyma, in which consolidation of the affected part and a filling of the alveolar
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More information4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES
CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial
More informationA retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya
A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya LU Edirisinghe 1, D Vidanagama 2 1 Senior Registrar in Medicine, 2 Consultant Microbiologist,
More information9/9/2015. Disclosure / Contact. Pneumonia Stats. Exploring the Clinical and Regulatory Impact of Pneumonia in Long Term Care
Exploring the Clinical and Regulatory Impact of Pneumonia in Long Term Care Rob Shulman R.Ph. CGP FASCP Director of Consulting Services Remedi SeniorCare William M. Vaughan,RN, BSN Vice President, Education
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationBacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India
ISSN: 2319-7706 Volume 4 Number 11 (2015) pp. 731-736 http://www.ijcmas.com Original Research Article Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching
More informationLeveraging the Lab and Microbiology Department to Optimize Stewardship
Leveraging the Lab and Microbiology Department to Optimize Stewardship Presented by: Andrew Martinez MLS(ASCP), MT(AMT), MBA Alaska Native Medical Center Microbiology Supervisor Maniilaq Health Center
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationSolution Title: Antibiotic Stewardship: A Journey Toward the Triple Aim
Solution Title: Antibiotic Stewardship: A Journey Toward the Triple Aim Program/Project Description, including Goals What was the problem to be solved? How was it identified? What baseline data existed?
More informationBad Bugs. Pharmacist Learning Objectives. Antimicrobial Resistance. Patient Case. Pharmacy Technician Learning Objectives 4/8/2016
Pharmacist Learning Objectives Antimicrobial Resistance Julie Giddens Pharm D, BCPS Infectious Disease Clinical Pharmacist OSF Saint Francis Medical Center Peoria, IL The speaker has no conflicts to disclose
More informationAcute Pyelonephritis POAC Guideline
Acute Pyelonephritis POAC Guideline Refer full regional pathway http://aucklandregion.healthpathways.org.nz/33444 EXCLUSION CRITERIA: COMPLICATED PYELONEPHRITIS Discuss with relevant specialist for advice
More informationGUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes
More informationPIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS
PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS The current supply of piperacillin- tazobactam should be reserved f Microbiology / Infectious Diseases approval and f neutropenic sepsis, severe sepsis
More informationSHC Clinical Pathway: HAP/VAP Flowchart
SHC Clinical Pathway: Hospital-Acquired and Ventilator-Associated Pneumonia SHC Clinical Pathway: HAP/VAP Flowchart v.08-29-2017 Diagnosis Hospitalization (HAP) Pneumonia develops 48 hours following: Endotracheal
More informationExamples of Antimicrobial Stewardship Interventions: a couple of starter projects
Examples of Antimicrobial Stewardship Interventions: a couple of starter projects Jennifer Ott, PharmD, BCPS Clinical Pharmacist Specialist Infectious Diseases Billings Clinic jott4@billingsclinic.org
More informationNew Antibiotics & New Insights into Old Antibiotics
New Antibiotics & New Insights into Old Antibiotics Louisiana Chapter of the American Academy of Pediatrics August 18, 2018 Baton Rouge, Louisiana John Bradley MD Rady Children s Hospital San Diego University
More informationAntimicrobial Therapy
Antimicrobial Therapy David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle Disclosure: Dr. Spach has no significant financial interest in any of the
More informationC&W Three-Year Cumulative Antibiogram January 2013 December 2015
C&W Three-Year Cumulative Antibiogram January 213 December 215 Division of Microbiology, Virology & Infection Control Department of Pathology & Laboratory Medicine Contents Comments and Limitations...
More informationTable 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.
Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Gram-positive cocci: Staphylococcus aureus: *Resistance to penicillin is almost universal. Resistance
More informationCost high. acceptable. worst. best. acceptable. Cost low
Key words I Effect low worst acceptable Cost high Cost low acceptable best Effect high Fig. 1. Cost-Effectiveness. The best case is low cost and high efficacy. The acceptable cases are low cost and efficacy
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationUpdate on Fluoroquinolones. Charles Krasner, M.D. June 16, 2016 Antibiotic Stewardship Program -ECHO
Update on Fluoroquinolones Charles Krasner, M.D. June 16, 2016 Antibiotic Stewardship Program -ECHO Potential fluoroquinolone side-effects Increased risk, greater than with most other antibiotics, for
More informationAntimicrobial Update Stewardship in Primary Care. Clare Colligan Antimicrobial Pharmacist NHS Forth Valley
Antimicrobial Update Stewardship in Primary Care Clare Colligan Antimicrobial Pharmacist NHS Forth Valley Setting the Scene! Consequences of Antibiotic Use? Resistance For an individual patient with
More informationAppropriate Antimicrobial Therapy for Treatment of
Appropriate Antimicrobial Therapy for Treatment of Staphylococcus aureus infections ( MRSA ) By : A. Bojdi MD Assistant Professor Inf. Dis. Dep. Imam Reza Hosp. MUMS Antibiotics Still Miracle Drugs Paul
More information21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review
(1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of
More informationTITLE: NICU Late-Onset Sepsis Antibiotic Practice Guideline
Site: Saint Joseph Hospital - NICU Original Effective Date: 6/1/2016 Next Review Date: 6/1/2019 TITLE: Practice Guideline Purpose: Timely and appropriate treatment of late-onset sepsis with antibiotic
More informationDisclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials
Disclosures Principles of Antimicrobial Therapy None Lori A. Cox MSN, ACNP-BC, ACNPC, FCCM Penn State Hershey Medical Center Neuroscience Critical Care Unit Obtaining an Accurate Diagnosis Determine site
More informationAntibiotic Stewardship at MetroWest Medical Center. Colleen Grocer, RPh, BCOP Co-Chair, Antibiotic Stewardship Committee
Antibiotic Stewardship at MetroWest Medical Center Colleen Grocer, RPh, BCOP Co-Chair, Antibiotic Stewardship Committee Antibiotic Stewardship Committee Subcommittee of Pharmacy and Therapeutics. Also
More informationSurgical infection ผ.ศ. น.พ. กำธร มำลำธรรม หน วยโรคต ดเช อ ภำคว ชำอำย รศำสตร คณะแพทยศำสตร โรงพยำบำลรำมำธ บด
Surgical infection ผ.ศ. น.พ. กำธร มำลำธรรม หน วยโรคต ดเช อ ภำคว ชำอำย รศำสตร คณะแพทยศำสตร โรงพยำบำลรำมำธ บด 1 Scope Surgical prophylaxis: Pharmacologic approach to prevent SSI Antimicrobial therapy for
More informationObjectives. Antibiotic Prophylaxis in Urologic Procedures: A Review of the CUA Guidelines & Local Epidemiology of Drug Resistance
Antibiotic Prophylaxis in Urologic Procedures: A Review of the CUA Guidelines & Local Epidemiology of Drug Resistance David Hogarth UBC Urology PGY-1 May 24, 2017 Objectives 1. To review the current CUA
More informationAntimicrobial Susceptibility Testing: The Basics
Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories
More information